EBRT plus brachytherapy does not improve outcomes over brachytherapy alone in patients with intermediate-risk prostate cancer, a phase 3 trial suggests. External beam radiation therapy (EBRT) plus ...

Brachytherapy-based regimens appear to be effective salvage treatment for localized radiorecurrent prostate cancer, investigators reported at the 2024 ASCO Genitourinary Cancers Symposium in San ...

Adding supplemental external beam radiotherapy (EBRT) did not improve outcomes in higher-risk cancer patients who had brachytherapy, according to the long-term results of two trials. Specifically, ...

One and done?: Utility of PSA density as a predictor of number of cores needed to detect clinically significant prostate cancer. This is an ASCO Meeting Abstract from the 2019 Genitourinary Cancers ...

To examine the difference in Prostate Specific Antigen (PSA)-Relapse Free Survival (RFS) in patients (pts) with prostate cancer treated with permanent prostate brachytherapy (PPB) alone (monotherapy) ...

When Chris Muraithi, turned 45, he started going for regular tests to check his prostate. One of the tests performed during his visits to a medical facility is one that measures the level of ...

NEW YORK (Reuters Health) - Among men with good sexual function before treatment with low-dose brachytherapy for prostate cancer, erectile function is likely to remain good over the long term, ...

Prostate brachytherapy is widely used to treat patients with low-risk prostate cancer, but its use in patients at high risk of extracapsular cancer extension (ECE) is controversial. Dattoli and ...

Please provide your email address to receive an email when new articles are posted on . Assessment of sexual function occurred far less often among women undergoing brachytherapy for cervical cancer ...